[en] The KDIGO guidelines propose a new approach to
diagnose chronic kidney disease (CKD) based on
estimated glomerular ®ltration rate (GFR). In patients
with a GFR value comprised between 45 and 59 mL/
min/1.73m2 as estimated by the CKD-EPI creatinine
equation (eGFRcreat), it is suggested to con®rm the
diagnosis with a second estimation using the CKD-EPI
cystatin C-based equations (eGFRcys/eGFRcreat-cys). We
sought to determine whether this new diagnostic
strategy might extend to kidney transplant recipients
(KTR) and help to identify those with decreased GFR. In
670 KTR for whom a measured GFR was available, we
simulated the detection of CKD using the two-steps
approach recommended by the guidelines in comparison
to the conventional approach relying on creatinine
equation. One hundred forty-®ve patients with no
albuminuria had eGFRcreat between 45 and 59 mL/
min/1.73m2. Among them, 23% had inulin clearance
over 60 mL/min/1.73m2 and were thus incorrectly
classi®ed as CKD patients. When applying the Kidney
Disease: Improving Global Outcomes (KDIGO) strategy,
138 patients were con®rmed as having a GFR below
60 mL/min with eGFRcreat-cys. However, 21% of them
were misclassi®ed in reference to measured GFR. Our
data do no not support the use of cystatin C as a
con®rmatory test of stage 3A CKD in KTR.
Disciplines :
Laboratory medicine & medical technology
Author, co-author :
Masson, I
Maillard, N
CAVALIER, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale
Alamartine, E
Mariat, C
DELANAYE, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie
Language :
English
Title :
KDIGO Guidelines and Kidney Transplantation: Is the cystatin-C Based Recommendation relevant?
Levin A, Stevens PE, Bilous RW, et al., Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150.
Levey AS, Coresh J, Bolton K, et al., K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
Inker LA, Schmid CH, Tighiouart H, et al., Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20-29.
Shlipak MG, Matsushita K, Arnlov J, et al., Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013; 369: 932-943.
Delanaye P, Mariat C,. The applicability of eGFR equations to different populations. Nat Rev Nephrol 2013; 9: 513-522.
Masson I, Maillard N, Tack I, et al., GFR estimation using standardized Cystatin C in kidney transplant recipients. Am J Kidney Dis 2013; 61: 279-284.
Schaeffner ES, Ebert N, Delanaye P, et al., Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012; 157: 471-481.
Levey AS, Stevens LA, Schmid CH, et al., A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
Issa N, Kukla A, Jackson S, et al., Comparison of cystatin C and creatinine-based equations for GFR estimation after living kidney donation. Transplantation 2014; 98: 871-877.
Hilden J, Gerds TA,. A note on the evaluation of novel biomarkers: Do not rely on integrated discrimination improvement and net reclassification index. Stat Med 2014; 33: 3405-3414.
Leening MJ, Vedder MM, Witteman JC, Pencina MJ, Steyerberg EW,. Net reclassification improvement: computation, interpretation, and controversies: A literature review and clinician's guide. Ann Intern Med 2014; 160: 122-131.
Perrone RD, Madias NE, Levey AS,. Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 1992; 38: 1933-1953.
Delanaye P, Cavalier E, Radermecker RP, et al., Cystatin C or creatinine for detection of stage 3 chronic kidney disease in Anorexia Nervosa. Nephron Clin Pract 2008; 110: c158-c163.
Segarra A, de la Torre J, Ramos N, et al., Assessing glomerular filtration rate in hospitalized patients: A comparison between CKD-EPI and four cystatin C-based equations. Clin J Am Soc Nephrol 2011; 6: 2411-2420.
Séronie-Vivien S, Delanaye P, Pieroni L, Mariat C, Froissart M, Cristol JP,. Cystatin C: Current position and future prospects. Clin Chem Lab Med 2008; 46: 1664-1686.
Rule AD, Bailey KR, Lieske JC, Peyser PA, Turner ST,. Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 2013; 83: 1169-1176.
Delanaye P, Schaeffner E, Ebert N, et al., Normal reference values for glomerular filtration rate: What do we really know? Nephrol Dial Transplant 2012; 27: 2664-2672.